Rexahn Pharmaceuticals Signs Development and Commercialization...

Full story: Med Ad News

Jun 29, 2009 - Rexahn Pharmaceuticals, Inc. , a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that it has signed an exclusive collaboration and option for license agreement with a top 20 global pharmaceutical company for the development of RX-3117. RX-3117 is a small ...

Leave a Comment

Comments

Type in your comments to post to the forum

Name
(appears on your post)

Comments

Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Other Recent Pancreatic Cancer Discussions

Topic	Updated	Last By	Comments
Research links sugar and pancreatic cancer (Jun '08)	Tue	CAG	20
What Is Esophageal Cancer? What Is Cancer Of Th...	Dec 2	drew richardson	1
A gift for Santa	Dec 1	Sister Sue	13
November is Lung Cancer Awareness Month	Nov 20	tulsa	25
'Never took for granted the greatest blessings ...	Nov '09	steve	1
Local woman develops Cancer-Warrior clothing, j...	Nov '09	Hope	5
Suzanne Somers Says Chemotherapy 'Poisoned' Pat...	Oct '09	Gail Perry	25